Also called Solar Keritosis, Actinic Keratosis is a rough, scaly patch of skin caused by prolonged exposure to ultraviolet (UV) rays from the sun or indoor tanning. Multiple individual Actinic Keritosis are referred to as Actinic Keritoses. AK lesions are often described as having a sandpaper-like feel and can be dark, light, red, pink, tan or a combination. AK is commonly found on the face, lips, ears, back of hands, forearms, scalp or neck. Not only are AK spots unsightly, they are also considered pre-cancerous. Untreated AK can lead to a common type of cancer called squamous cell carcinoma.
While fair skinned people are more susceptible to AK, all skin types should limit exposure to UV rays as prevention is the best form of treatment. But, if you think you may have AK, you should seek evaluation and be followed by a dermatologist to confirm AK and provide close monitoring and treatment, if necessary.
Various treatments are approved for AK such as 5-fluorouracil cream, a cancer-fighting topical cream, or ingenol mebutate, a gel that promotes cell death. While these treatments have been proven effective, they also come with side effects and may not be suitable for all patients.
New treatments are needed for AK and research is currently being conducted to help find new treatments that might be more effective and have less side effects. Shrock Clinical Research, in Fort Lauderdale, FL, is currently conducting studies on new potential treatments for those with AK. If you have been diagnosed with AK or think you might have AK, volunteering for a research study might be a great way for you to further understand your condition, be seen by a board-certified dermatologist and have your AK monitored for the duration of the study. Additionally, you may be able to receive investigational treatment for your AK while in the study.
Volunteers in medical research studies receive focused care and attention from a dermatologist and their research staff to help ensure safety throughout the study. Additionally, participants often learn more about their condition and are compensated for their time and travel expenses.
To learn more about AK treatment options or to find out about AK studies, call Shrock Clinical Research at (954) 626-3743.